Software Firm GitLab Prices US$800 Million IPO

Software company GitLab Inc. (Nasdaq: GTLB) started trading on the Nasdaq Global Select Market Thursday under the ticker symbol “GTLB”. The firm aims to raise US$800.8 million in its debut on the big board.

The offering consisted of 10.4 million Class A common shares at US$77.00 per share. The company is selling 8.42 million shares out of the offering while the remaining 1.98 million shares will be sold by the existing stockholder affiliated with GitLab CEO and chair Sytse Sijbrandij. GitLab said it will not receive any proceeds from the latter.

Goldman Sachs & Co., J.P. Morgan, and BofA Securities are acting as the lead bookrunners for the said offering. The underwriters were given a 30-day over-allotment option to purchase up to an additional 1.04 million shares at the same IPO price.

Silver47 Exploration Inc. — sponsored Sponsored · Silver47 Exploration Inc.

The offering is expected to close on October 18, 2021, subject to customary closing conditions.


Information for this briefing was found via Sedar and the companies mentioned. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Why I’m Still Bullish on Gold Below $3,900 | Wes Hanson – Thunder Gold

Is Agnico Eagle Seabridge Gold’s Mystery Lender?

This Gold Giant Is Building 1.5 Million More Ounces a Year | Agnico Eagle Q3 Earnings

Recommended

Epic Gold Delivers Maiden 279,000 Ounce Inferred Resource at Wilson Project

First Phosphate Adds UK Export Finance to Growing Export Credit Lineup With C$220 Million Letter of Interest

Related News

Ex-Wipro CEO-led SPAC Compass Digital Acquisition Prices US$200 Million IPO

Special purpose acquisition company Compass Digital Acquisition Corp. (Nasdaq: CDAQU) started trading publicly on the...

Friday, October 15, 2021, 02:27:00 PM

Biotech Firm AN2 Therapeutics Prices US$69 Million IPO

Biopharmaceutical company AN2 Therapeutics, Inc. (Nasdaq: ANTX) began trading on the Nasdaq Global Select Market...

Friday, March 25, 2022, 02:22:00 PM

It’s Been A Painful Year For IPOs, Proceeds Are Down 93%

It hasn’t been a good year for companies going public  — uncertainty from mounting recession...

Monday, December 5, 2022, 03:06:00 PM

Fintech Firm-Backed SPAC FTAC Emerald Acquisition Prices US$220 Million IPO

Special purpose acquisition company FTAC Emerald Acquisition Corp. (Nasdaq: EMLDU) started trading publicly on the...

Thursday, December 16, 2021, 02:22:00 PM

SPAC Portage Fintech Acquisition Upsizes IPO To US$240 Million

Special purpose acquisition company Portage Fintech Acquisition Corporation (Nasdaq: PFTAU) announced Tuesday that it is...

Wednesday, July 21, 2021, 12:03:00 PM